期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

一例蒽环类药物心脏毒性的用药分析 被引量：2

A Case Analysis of Cardiotoxicity Caused by Anthracycline
下载PDF
导出
摘要 蒽环类药物的剂量限制性心脏毒性限制了其在临床上的应用。本文就一例恶性淋巴瘤患者用药后出现的心脏毒性反应,对蒽环类药物心脏毒性的发生机制、危险因素、监测和防治等方面作一综述。 The clinical application of anthracycline is restricted because of its cardiotoxicity. This article summarized the mechanism, risk factors, monitoring and prevention of anthracycline induced cardiotoxicity by analysis of a patient with malignant lymphoma who had cardiotoxicity after the medication.
作者 徐巍 刘晓琳 苏乐群 李宏建
机构地区 山东省千佛山医院药学部 山东省千佛山医院肿瘤科
出处 《药品评价》 CAS 2012年第20期31-33,共3页 Drug Evaluation
关键词 蒽环类药物 心脏毒性 淋巴瘤 Anthracycline Cardiotoxicity Lymphoma
分类号 R733.1 [医药卫生—肿瘤]
  • 相关文献

参考文献6

  • 1Swain SM,Whaley FS,EwerMS.Congestive heart failure in patients treated with doxorubicin:a retrospective analysis of three trials[J].Cancer,2003,97(11):2869-2879.
  • 2Simunek T,Sterba M,Popelova O.Anthracycline-induced cardiotoxicity:overview of studies examining the roles of oxidative stress and free cellular iron[J].Pharmacol Rep,2009,61(1):154-171.
  • 3Cusack BJ,GamblielH,MusserB,et al.Prevention of chronic anthracycline cardiotoxicity in the adult Fischer 344 rat by dexrazoxane and effects on iron metabolism[J].Cancer Chemother Pharmacol 2006,58(4):517-526.
  • 4Fisher PW,Salloum F,DasA,et al.Phosphodiesterase-5 inhibition with sildenafil attenuates cardiomyocyte apoptosis and left ventricular dysfunction in a chronic model of doxorubicin cardiotoxicity[J].Circulation,2005,111(13):1601-1610.
  • 5Cvetkovi RS,Scott LJ.Dexrazoxane:a review of its use for cardioprotection during anthracycline chemotherapy[J].Drugs,2005;65(7):1005-1024.
  • 6Kim KH,Oudit GY,Backx PH.Erythropoietin protects against doxorubicin-induced cardiomyopathy via a phosphatidylinositol 3-kinasedependent pathway[J].J Pharmacol Exp Ther,2008;324(1):160-169.

同被引文献15

  • 1Saidi A, Alharethi R. Management of chemotherapy ind- uced cardiomyopathy[J]. Cur Cardiol Rev, 2011,7 (4): 245-249.
  • 2Lipshultz SE, Rifai N, Dalton VM, et al. The effect of dexrazoxane on myocardial injury in doxorubiein--treat- ed children with acute lymphpblastie leukemia [J]. N Engl Med, 2004,35 l (2) : 145.
  • 3Beata B, Joanna N. Prognostic potential of topoisomerase IIa and HER-2 in a retrospective analysis of early advanced breast caneer patients treated with adjuvant anthracycline chemotherapy[ J ]. Breast,2011,3 : 1-13.
  • 4Van Dongen JA, Voogd AC, Fentinan IS, et al. Long-term results of a randomized trial comparing breast conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer [ J ]. Trial, 2000,92 ( 14 ) : 1143- 1150.
  • 5Goldhirsch A, Ingle JN, Gelber RD, et al. Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009[J]. Annals of Oncology , 2009,20(8) :1319-1329.
  • 6胡夕春,王碧芸.转移性乳腺癌内科治疗进展[J].中国临床肿瘤学进展,2010,8:281-283.
  • 7Voravud N, Phase II trial of ramosetron plus dexamethaso- nein the prevention of cisplatin-induced nausea and vomiting [ J]. MedAssoc Thai ,2005, 88 (12) : 1790-1796.
  • 8Larrey D, Pageaux GP. Drug-induced acute liver failure [ J ]. Eur J Gastroenterol Hepatol,2005,17 : 141-143.
  • 9Kosmas C, Kallistratos M, Kopterides P, et al. Cardiotoxici- ty of fluoropyrinidines in different schedules of administra- tion: a prospective study[ J ]. J Cancer Res Clin Oncol,2008, 134 : 75-82.
  • 10张竞竞,孙惠娟.蒽环类抗肿瘤药物的心脏毒性[J].临床肺科杂志,2008,13(3):325-326. 被引量：22

引证文献2

二级引证文献2

药品评价
2012年 第20期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部